Selected research
Industry Research
Autologous Immune Cell Storage Industry Research Report 2026
Market perspective
The global Autologous Immune Cell Storage market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Autologous Immune Cell Storage market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Autologous Immune Cell Storage market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Autologous Immune Cell Storage market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Autologous Immune Cell Storage include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Autologous Immune Cell Storage market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Autologous Immune Cell Storage.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Autologous Immune Cell Storage Market by Company
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
VCANBIO Cell and Gene Engineering Corp., Ltd.
Shenzhen Beike Bio-Technology Co.,Ltd
Beijing Health and Biotech Group Corp. Ltd.
Shanghai Cell Therapy Group Co. Ltd.
BGI Genomics
Shanghai Saiyao Biotechnology Co., Ltd.
Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Autologous Immune Cell Storage Segment by Type
Lymphocyte Storage
Hematopoietic Stem Cell Storage
Autologous Immune Cell Storage Segment by Application
Treat Leukemia and Blood-Related Diseases
Immune System Modulation
Stem Cell Transplant
Autologous Immune Cell Storage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autologous Immune Cell Storage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autologous Immune Cell Storage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autologous Immune Cell Storage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Autologous Immune Cell Storage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lymphocyte Storage
- Hematopoietic Stem Cell Storage
Applications
- Treat Leukemia and Blood-Related Diseases
- Immune System Modulation
- Stem Cell Transplant
Companies covered
- HealthBanks
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
- STEMCELL
- Enhance Biomedical
- Immunaeon
- Miracell
- VCANBIO Cell and Gene Engineering Corp., Ltd.
- Shenzhen Beike Bio-Technology Co.,Ltd
- Beijing Health and Biotech Group Corp. Ltd.
- Shanghai Cell Therapy Group Co. Ltd.
- BGI Genomics
- Shanghai Saiyao Biotechnology Co., Ltd.
- Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Autologous Immune Cell Storage by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Lymphocyte Storage
- 2.2.3 Hematopoietic Stem Cell Storage
- 2.3 Autologous Immune Cell Storage by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Treat Leukemia and Blood-Related Diseases
- 2.3.3 Immune System Modulation
- 2.3.4 Stem Cell Transplant
- 2.4 Assumptions and Limitations
3 Autologous Immune Cell Storage Breakdown Data by Type
- 3.1 Global Autologous Immune Cell Storage Historic Market Size by Type (2021-2026)
- 3.2 Global Autologous Immune Cell Storage Forecasted Market Size by Type (2027-2032)
4 Autologous Immune Cell Storage Breakdown Data by Application
- 4.1 Global Autologous Immune Cell Storage Historic Market Size by Application (2021-2026)
- 4.2 Global Autologous Immune Cell Storage Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Autologous Immune Cell Storage Market Perspective (2021-2032)
- 5.2 Global Autologous Immune Cell Storage Growth Trends by Region
- 5.2.1 Global Autologous Immune Cell Storage Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Autologous Immune Cell Storage Historic Market Size by Region (2021-2026)
- 5.2.3 Autologous Immune Cell Storage Forecasted Market Size by Region (2027-2032)
- 5.3 Autologous Immune Cell Storage Market Dynamics
- 5.3.1 Autologous Immune Cell Storage Industry Trends
- 5.3.2 Autologous Immune Cell Storage Market Drivers
- 5.3.3 Autologous Immune Cell Storage Market Challenges
- 5.3.4 Autologous Immune Cell Storage Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Autologous Immune Cell Storage Players by Revenue
- 6.1.1 Global Top Autologous Immune Cell Storage Players by Revenue (2021-2026)
- 6.1.2 Global Autologous Immune Cell Storage Revenue Market Share by Players (2021-2026)
- 6.2 Global Autologous Immune Cell Storage Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Autologous Immune Cell Storage Head Office and Area Served
- 6.4 Global Autologous Immune Cell Storage Players, Product Type & Application
- 6.5 Global Autologous Immune Cell Storage Manufacturers Established Date
- 6.6 Global Autologous Immune Cell Storage Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Autologous Immune Cell Storage Market Size (2021-2032)
- 7.2 North America Autologous Immune Cell Storage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 7.4 North America Autologous Immune Cell Storage Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Autologous Immune Cell Storage Market Size (2021-2032)
- 8.2 Europe Autologous Immune Cell Storage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 8.4 Europe Autologous Immune Cell Storage Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Autologous Immune Cell Storage Market Size (2021-2032)
- 9.2 Asia-Pacific Autologous Immune Cell Storage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Autologous Immune Cell Storage Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Autologous Immune Cell Storage Market Size (2021-2032)
- 10.2 South America Autologous Immune Cell Storage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 10.4 South America Autologous Immune Cell Storage Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Autologous Immune Cell Storage Market Size (2021-2032)
- 11.2 Middle East & Africa Autologous Immune Cell Storage Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 HealthBanks
- 12.1.1 HealthBanks Company Information
- 12.1.2 HealthBanks Business Overview
- 12.1.3 HealthBanks Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.1.4 HealthBanks Autologous Immune Cell Storage Product Portfolio
- 12.1.5 HealthBanks Recent Developments
- 12.2 Aeterna Health
- 12.2.1 Aeterna Health Company Information
- 12.2.2 Aeterna Health Business Overview
- 12.2.3 Aeterna Health Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.2.4 Aeterna Health Autologous Immune Cell Storage Product Portfolio
- 12.2.5 Aeterna Health Recent Developments
- 12.3 Cell Vault
- 12.3.1 Cell Vault Company Information
- 12.3.2 Cell Vault Business Overview
- 12.3.3 Cell Vault Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.3.4 Cell Vault Autologous Immune Cell Storage Product Portfolio
- 12.3.5 Cell Vault Recent Developments
- 12.4 Redermis
- 12.4.1 Redermis Company Information
- 12.4.2 Redermis Business Overview
- 12.4.3 Redermis Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.4.4 Redermis Autologous Immune Cell Storage Product Portfolio
- 12.4.5 Redermis Recent Developments
- 12.5 Innovita Research
- 12.5.1 Innovita Research Company Information
- 12.5.2 Innovita Research Business Overview
- 12.5.3 Innovita Research Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.5.4 Innovita Research Autologous Immune Cell Storage Product Portfolio
- 12.5.5 Innovita Research Recent Developments
- 12.6 STEMCELL
- 12.6.1 STEMCELL Company Information
- 12.6.2 STEMCELL Business Overview
- 12.6.3 STEMCELL Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.6.4 STEMCELL Autologous Immune Cell Storage Product Portfolio
- 12.6.5 STEMCELL Recent Developments
- 12.7 Enhance Biomedical
- 12.7.1 Enhance Biomedical Company Information
- 12.7.2 Enhance Biomedical Business Overview
- 12.7.3 Enhance Biomedical Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.7.4 Enhance Biomedical Autologous Immune Cell Storage Product Portfolio
- 12.7.5 Enhance Biomedical Recent Developments
- 12.8 Immunaeon
- 12.8.1 Immunaeon Company Information
- 12.8.2 Immunaeon Business Overview
- 12.8.3 Immunaeon Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.8.4 Immunaeon Autologous Immune Cell Storage Product Portfolio
- 12.8.5 Immunaeon Recent Developments
- 12.9 Miracell
- 12.9.1 Miracell Company Information
- 12.9.2 Miracell Business Overview
- 12.9.3 Miracell Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.9.4 Miracell Autologous Immune Cell Storage Product Portfolio
- 12.9.5 Miracell Recent Developments
- 12.10 VCANBIO Cell and Gene Engineering Corp., Ltd.
- 12.10.1 VCANBIO Cell and Gene Engineering Corp., Ltd. Company Information
- 12.10.2 VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview
- 12.10.3 VCANBIO Cell and Gene Engineering Corp., Ltd. Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.10.4 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Product Portfolio
- 12.10.5 VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Developments
- 12.11 Shenzhen Beike Bio-Technology Co.,Ltd
- 12.11.1 Shenzhen Beike Bio-Technology Co.,Ltd Company Information
- 12.11.2 Shenzhen Beike Bio-Technology Co.,Ltd Business Overview
- 12.11.3 Shenzhen Beike Bio-Technology Co.,Ltd Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.11.4 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Product Portfolio
- 12.11.5 Shenzhen Beike Bio-Technology Co.,Ltd Recent Developments
- 12.12 Beijing Health and Biotech Group Corp. Ltd.
- 12.12.1 Beijing Health and Biotech Group Corp. Ltd. Company Information
- 12.12.2 Beijing Health and Biotech Group Corp. Ltd. Business Overview
- 12.12.3 Beijing Health and Biotech Group Corp. Ltd. Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.12.4 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Product Portfolio
- 12.12.5 Beijing Health and Biotech Group Corp. Ltd. Recent Developments
- 12.13 Shanghai Cell Therapy Group Co. Ltd.
- 12.13.1 Shanghai Cell Therapy Group Co. Ltd. Company Information
- 12.13.2 Shanghai Cell Therapy Group Co. Ltd. Business Overview
- 12.13.3 Shanghai Cell Therapy Group Co. Ltd. Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.13.4 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Product Portfolio
- 12.13.5 Shanghai Cell Therapy Group Co. Ltd. Recent Developments
- 12.14 BGI Genomics
- 12.14.1 BGI Genomics Company Information
- 12.14.2 BGI Genomics Business Overview
- 12.14.3 BGI Genomics Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.14.4 BGI Genomics Autologous Immune Cell Storage Product Portfolio
- 12.14.5 BGI Genomics Recent Developments
- 12.15 Shanghai Saiyao Biotechnology Co., Ltd.
- 12.15.1 Shanghai Saiyao Biotechnology Co., Ltd. Company Information
- 12.15.2 Shanghai Saiyao Biotechnology Co., Ltd. Business Overview
- 12.15.3 Shanghai Saiyao Biotechnology Co., Ltd. Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.15.4 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Product Portfolio
- 12.15.5 Shanghai Saiyao Biotechnology Co., Ltd. Recent Developments
- 12.16 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
- 12.16.1 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Information
- 12.16.2 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview
- 12.16.3 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Revenue in Autologous Immune Cell Storage Business (2021-2026)
- 12.16.4 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Product Portfolio
- 12.16.5 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst